Eighteen months on from the start of NHS England’s hepatitis C elimination deal, HCV Action’s annual ODN event, co-hosted with the British Viral Hepatitis Group, explored how the UK has progressed towards elimination. It particularly focused on overcoming the challenges posed by the significant disruption of Covid-19 on healthcare services. This year’s event was held as a half-day webinar due to coronavirus-related restrictions and welcomed 129 participants from almost all ODNs and partner services.
Hepatitis C: Increasing Awareness and Improving Access to Testing for the South Asian Community in Bedford
Download
In the United Kingdom (UK), the majority of individuals infected with Hepatitis C are past or present injecting drug users. However, there is a higher than average HCV prevalence among the South Asian community compared with the general population in the UK. For instance, the Pakistani community has been noted as having a greater than 2% prevalence of HCV, despite the majority of them never having injected drugs. This presents a serious public health challenge as ethnic minorities are known to access health services quite late in the course of their illness compared to the general population. Therefore, they are less likely to be diagnosed and treated for HCV before advanced liver disease or premature death occurs. This is a concern for Bedford, where there are approximately 13,500 South Asians. It is thus urgent that awareness about the disease is increased, that those iindividuals that may be infected with HCV are identified through health education, opportunistic case finding and voluntary testing after appropriate counselling in order to offer appropriate treatment.
This project, which was targeted at the South Asian Community in Bedford, aimed to increase awareness of HCV, improve access to HCV testing, and assess the prevalence of the HCV antibody by testing individuals to determine exposure to the virus.
